Suppr超能文献

终末期慢性阻塞性肺疾病

End stage chronic obstructive pulmonary disease.

作者信息

Ambrosino Nicolino, Gherardi Marco, Carpenè Nicoletta

机构信息

Respiratory Intensive Care and Pulmonary Diseases Unit, Cardio-Thoracic Department, University Hospital Pisa, Cisanello 56127 Pisa, Italy.

出版信息

Pneumonol Alergol Pol. 2009;77(2):173-9.

Abstract

Many patients with chronic obstructive pulmonary disease (COPD) die each year as those with lung cancer but current guidelines make few recommendations on the care for the most severe patients i.e. those with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages III and IV with chronic respiratory failure. Only smoking cessation and long term oxygen therapy (LTOT) improve survival in COPD. Although non invasive positive pressure ventilation (NPPV) may have an adjunctive role in the management of chronic respiratory insufficiency there is little evidence for its use in the routine management of stable hypercapnic COPD patients. At difference, several prospective, randomised, controlled studies, systematic reviews and meta-analyses show good level of evidence for clinical efficacy of NPPV in the treatment of acute on chronic respiratory failure due to acute exacerbations of COPD. NPPV is also alternative to invasive ventilation for symptom relief in end stage COPD. Surgical interventions for end stage COPD like bullectomy, different modalities of lung volume reduction surgery and lung transplantation are likely to be of value to only a small percentage of patients. Nevertheless, there are specific indications, which, when added to pulmonary rehabilitation will further advance exercise capacity and quality of life. As in other chronic diseases when severity of disease increases along the natural history, therapy aimed to prolong life becomes less and less important in comparison to palliative therapy aimed to relieve symptoms. The most effective treatments for dyspnoea are bronchodilators, although also opiates may improve dyspnoea. Supplemental oxygen reduce exertional breathlessness and improve exercise tolerance in hypoxaemic COPD patients. There are difficulties in treating with antidepressant the frail and elderly COPD patients. Good clinical care can prevent or alleviate suffering by assessing symptoms and providing psychological and social support to the patients and their families.

摘要

每年有许多慢性阻塞性肺疾病(COPD)患者死亡,人数与肺癌患者相当,但当前指南对最严重患者(即慢性呼吸衰竭的慢性阻塞性肺疾病全球倡议组织(GOLD)III期和IV期患者)的护理建议极少。在COPD中,只有戒烟和长期氧疗(LTOT)能提高生存率。尽管无创正压通气(NPPV)在慢性呼吸功能不全的管理中可能起辅助作用,但几乎没有证据表明其可用于稳定的高碳酸血症COPD患者的常规管理。不同的是,多项前瞻性、随机对照研究、系统评价和荟萃分析表明,有充分证据证明NPPV在治疗COPD急性加重所致慢性呼吸衰竭方面具有临床疗效。NPPV也是终末期COPD缓解症状的有创通气替代方法。终末期COPD的手术干预,如肺大疱切除术、不同方式的肺减容手术和肺移植,可能仅对一小部分患者有价值。然而,存在特定的适应症,将其与肺康复相结合可进一步提高运动能力和生活质量。与其他慢性疾病一样,随着疾病自然进程中病情严重程度增加,与旨在缓解症状的姑息治疗相比,旨在延长生命的治疗变得越来越不重要。治疗呼吸困难最有效的方法是支气管扩张剂,尽管阿片类药物也可能改善呼吸困难。补充氧气可减轻低氧血症COPD患者运动时的气短并提高运动耐力。治疗体弱和老年COPD患者时使用抗抑郁药存在困难。良好的临床护理可通过评估症状并为患者及其家人提供心理和社会支持来预防或减轻痛苦。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验